Skip to content

A study for evaluating the effects of oral intake of microorganism-originated food on antivirus reaction of immune cells.

A study for evaluating the effects of oral intake of microorganism-originated food on antivirus reaction of immune cells. - A study for the effects of microorganism-originated food on antivirus reaction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027531
Enrollment
110
Registered
2017-05-30
Start date
2014-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy adults)

Interventions

Microorganism-originated food, 1 portion of food per day for 4 weeks. Placebo (not containing microorganism-originated food), 1 portion of food per day for 4 weeks.

Sponsors

Kirin Company, Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged from 20 to less than 60 years old, when giving the informed consent. 2) Individuals work in daytime and do not have night shift. 3) Individuals who can avoid eating foods containing food originated from a microorganism 4) Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will. 5) Individuals who can accomplish their tasks in the study at the appointed date. 6) Individuals who are judged suitable for this study by the investigators.

Exclusion criteria

Exclusion criteria: 1) Individuals who can't avoid medication which effects on the results. 2) Individuals who can't avoid functional foods which effects on the results. 3) Individuals who are pregnant or willing to be pregnant. Individuals who are breast-feeding. 4) Individuals who are enrolled in other clinical trials. 5) Individuals who have a medical history of serious hepatopathy, nephropathy, or heart disease. 6) Individuals who have a medical history of viral hepatitis. 7) Individuals who have serious anemia. 8) Individuals who have serious hay fever symptoms and cannot avoid steroidal agents. 9) Individuals who are judged unsuitable for this study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Activities of immunocytes (Neutrophil phagoctytosis activities etc.)

Countries

Japan

Contacts

Public ContactToshio Fujii

Kirin Company, Limited Research Laboratories for Health Science & Food Technologies

tfujii@kirin.co.jp045-330-9837

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026